Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street closes lower as oil prices jump, indexes notch monthly gains
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
- Energy stocks rally as fresh U.S.-Iran attacks drive oil prices higher
- BofA turns S&P 500 signals from red to yellow: What to buy now
Roth Capital Raises Price Target on Lannett (LCI) Following Acquisition of Kremers Urban Pharmaceuticals
September 3, 2015 8:18 AM EDTRoth Capital reiterated a Buy rating on Lannett Co (NYSE: LCI), and raised the price target to $68.00 (from $62.00), following the transformative acquisition of Kremers Urban Pharmaceuticals. The transaction almost doubles the revenue base for LCI, and suggests 2016 EPS accretion of mid-to-high single digits and 20-25%... More
